UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003933 |
|---|---|
| Receipt number | R000004728 |
| Scientific Title | Phase II trial of amrubicin and cisplatin chemotherapy for invasive thymoma |
| Date of disclosure of the study information | 2010/08/01 |
| Last modified on | 2023/06/06 10:41:56 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/07/21 14:17:11 | ||
| 2 | Update | 2011/06/01 10:06:00 | Recruitment status |
|
| 3 | Update | 2015/01/07 13:11:37 | Recruitment status |
|
| 4 | Update | 2017/05/30 10:38:44 | Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2019/01/25 09:13:19 | Recruitment status Publication of results |
|
| 6 | Update | 2023/06/06 10:41:56 | Recruitment status Date of IRB Last follow-up date |
